Table 3.
Feet-ESC < 50μS | |||||||
Sensitivity | Specificity | AUC | PPV | NPV | +LH | -LH | |
DPN:VPT ≥ 25v | 90.1 | 77 | 0.841 | 13 | 99 | 3.98 | 0.12 |
DPN:NDS ≥ 3 | 61.2 | 85.2 | 0.732 | 54 | 85 | 4.12 | 0.46 |
RFU:NDS ≥ 6 | 63.8 | 81.9 | 0.729 | 40 | 92 | 3.53 | 0.44 |
Confirmed-DPN | 38.4 | 91 | 0.648 | 85.7 | 52 | 4.3 | 0.67 |
Feet-ESC <70μS | |||||||
DPN:VPT ≥ 25v | 100 | 46 | 0.732 | 6.7 | 100 | 1.86 | 0 |
DPN:NDS ≥ 3 | 80.6 | 51 | 0.663 | 32.5 | 90 | 1.66 | 0.38 |
RFU:NDS ≥ 6 | 80.9 | 49 | 0.651 | 23 | 93 | 1.59 | 0.39 |
Confirmed-DPN | 67.2 | 58.9 | 0.63 | 93 | 56 | 1.6 | 0.56 |
DPN diabetic peripheral neuropathy. RFU risk of foot ulceration. ESC electrochemical skin conductance. VPT vibration perception threshold. NDS neuropathy disability score. AUC area under the curve. PPV positive predictive value. NPV negative predictive value. +LH positive likelihood. –LH negative likelihood